Recurrent S. Aureus Infections in Osteoarticular Infections
NCT ID: NCT04712123
Last Updated: 2022-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2021-08-01
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to improve knowledge on persistence of mechanisms of S. aureus
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers
NCT02945722
S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
NCT04666532
S. Aureus, Skin and Soft Tissue Infections
NCT02796742
Staphylococcus Aureus Nasal Carriage
NCT02796690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
relapse due to S. aureus
patients having had an initial infection due to S. aureus and who present a relapse with persistence of S. aureus
relapse due to S. aureus
to find out if it is the same S. aureus in both infections
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
relapse due to S. aureus
to find out if it is the same S. aureus in both infections
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
281
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.